0001209191-12-031704.txt : 20120601 0001209191-12-031704.hdr.sgml : 20120601 20120601170455 ACCESSION NUMBER: 0001209191-12-031704 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20120530 FILED AS OF DATE: 20120601 DATE AS OF CHANGE: 20120601 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: BOGER JOSHUA S CENTRAL INDEX KEY: 0001197023 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-19319 FILM NUMBER: 12884084 MAIL ADDRESS: STREET 1: 130 WAVERLY STREET CITY: CAMBRIDGE STATE: MA ZIP: 02139 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: VERTEX PHARMACEUTICALS INC / MA CENTRAL INDEX KEY: 0000875320 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 043039129 STATE OF INCORPORATION: MA FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 130 WAVERLY STREET CITY: CAMBRIDGE STATE: MA ZIP: 02139-4242 BUSINESS PHONE: 6165776000 4 1 doc4.xml FORM 4 SUBMISSION X0305 4 2012-05-30 0 0000875320 VERTEX PHARMACEUTICALS INC / MA VRTX 0001197023 BOGER JOSHUA S C/O VERTEX PHARMACEUTICALS INCORPORATED 130 WAVERLY ST CAMBRIDGE MA 02139 1 0 0 0 Common Stock 2012-05-30 4 M 0 4000 15.60 A 636895 D Common Stock 2012-05-30 4 S 0 1700 57.92 D 635195 D Common Stock 2012-05-30 4 S 0 800 58.75 D 634395 D Common Stock 2012-05-30 4 S 0 900 59.98 D 633495 D Common Stock 2012-05-30 4 S 0 600 60.43 D 632895 D Common Stock 13286 I 401(k) Common Stock 300000 I Common Stock held in trust. Stock Option 15.60 2012-05-30 4 M 0 4000 0.00 D 2013-01-17 Common Stock 4000 122951 D Stock Option 59.55 2012-06-01 4 A 0 20000 0.00 A 2012-06-01 2022-05-31 Common Stock 20000 20000 D Transaction made pursuant to Dr. Boger's company approved trading plan under Rule 10b5-1. Open market sales reported on this line occurred at a weighted average price of $57.92 (range $57.28 to $58.12). Dr. Boger undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price. Open market sales reported on this line occurred at a weighted average price of $58.75 (range $58.31 to $59.30). Open market sales reported on this line occurred at a weighted average price of $59.98 (range $59.32 to $60.25). Open market sales reported on this line occurred at a weighted average price of $60.43 (range $60.32 to $60.59). Common stock held in grantor retained annuity trusts. Fully vested. David T. Howton, Attorney-In-Fact 2012-06-01